Navigate Fool.com
Will BAYRY beat
the market?


Community Rating: 3 Stars: Appealing

132.83 -2.93 (-2.16%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $134.56
Previous Close $135.76
Daily Range $132.35 - $134.69
52-Week Range $108.45 - $145.20
Market Cap $109.8B
P/E Ratio 754.22
Dividend (Yield) $0.00 (1.6%)
Volume 13,936
Average Daily Volume 50,656
Current FY EPS $8.23

How do you think BAYRY
will perform against the market?

Top BAYRY Bull/Bear Pitches


wilkeh (< 20)
Submitted June 6, 2013

strong pharma business (Xarelto, Eylea, Stivarga, Xofigo and Riociguat) with peak sales potential of €5.5 billions. further improvements in CropScience, capacity additions in MaterialScience will be a … More

0 Replies Reply Report this Post

TRGoodvsEvil (< 20)
Submitted July 4, 2009

This portfolio tracks the performance of good vs. evil companies. Evil attributes: -4th largest toxic polluter in the world (http://www.peri.umass.edu/toxic100_index/) -Inventor of mustard gas and he … More

3 Replies Reply Report this Post

News & Commentary

New Study Touts Benefits of Organic Goods, Questions Pesticides and GMOs

Though not earth-shattering, the largest study to date represents a continued move away from chemical use.

Regeneron's $4.7 Billion Opportunity

Regeneron recently got some good news. Check out the video below for more information.

Why Are These 3 Dow Jones Stocks Crushing the Market in 2014?

Intel, Caterpillar, and Merck were the Dow's best performers in the first half of 2014. Why did these three stocks race ahead, and where are they going next?

Why OncoMed Pharmaceuticals Inc. Shares Collapsed

OncoMed shares dive after it voluntarily halts two early-stage programs. Find out what investors should be closely monitoring going forward.

Wednesday’s Top Biotech Stories: Orexigen, Portola, and Regeneron

Orexigen, Portola, and Regeneron could all make waves across the health care sector this Wednesday morning.

Why Bayer Sold This Division to Boston Scientific

Why this acquisition made sense for both sides.

Good News at Boston Scientific: What's Next

Three recent developments help Boston Scientific, but don't fundamentally alter the thesis

Does This Study Prove Monsanto Company is Killing Our Honey Bees?

A class of insecticides has long been claimed to be at the root of the demise of honey bee populations. Do the data show that Monsanto, Bayer, and Syngenta are to blame?

Monday’s Top Health Care Stories: AstraZeneca, Pfizer, Intermune, and Compugen

AstraZeneca, Pfizer, Intermune, and Compugen could loom large in health care headlines this Monday morning.

Boston Scientific to Spend $415 Million on Bayer Division

Bayer says the sale will allow its health care unit to focus on growing its radiology and diabetes care segments.

See More BAYRY News...





Bayer AG (ADR) (BAYRY) Description

The Company offers products, including ethical pharmaceuticals and other health care products, agricultural products and polymers. Website:

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks